GGrantIndex
Sort

53,477 grants matching addiction

Novel Medications for Cannabis Dependence

$562,171
Alexandros Makriyannis · Northeastern University · R01 · FY2012 · DA

Implementation of Technology-Based Evaluation of Motivational Interviewing

$562,148
David Charles Atkins · University Of Washington · R01 · FY2020 · AA

Synaptic Actions of Amphetamine in the Striatum

$562,138
Stephen G Rayport · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2023 · DA

Strengthening Addiction Care Continuum through Community Consortium in Vietnam

$562,132
Li Li · University Of California Los Angeles · R01 · FY2021 · DA

Biomarkers of toxic response to low nicotine cigarette smoke

$562,125
Ian Alexander Blair · University Of Pennsylvania · R01 · FY2011 · CA

Sensitive periods for interneuron development supporting cognitive flexibility

$562,115
Sarah E Canetta · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2023 · MH

Sensitive periods for interneuron development supporting cognitive flexibility

$562,114
Sarah E Canetta · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2024 · MH

Sensitive periods for interneuron development supporting cognitive flexibility

$562,114
Sarah E Canetta · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2025 · MH

Investigation of Synthetic Cannabinoid Exposures and Pharmacological Consequences

$562,088
Rangan Maitra · Research Triangle Institute · R01 · FY2025 · DA

Discovery of Chemical Probes for Psychiatric Disorders and Addiction

$562,032
Fernanda Laezza · University Of Texas Med Br Galveston · R01 · FY2018 · MH

Neuropsychopharmacology: Multidisciplinary Training

$562,020
Michael A Taffe · Scripps Research Institute, The · T32 · FY2017 · AA

Opioid actions on the habenulo-peduncular circuit

$562,014
Thomas Hnasko · University Of California, San Diego · R01 · FY2024 · DA

HIV and Psychiatric Comorbidity: Selected Genetic and Epigenetic Factors

$561,991
Mary J Kreek · Rockefeller University · R01 · FY2007 · MH

Multiomic profiling of cell types mediating opioid use disorder in rats

$561,976
Francesca Telese · University Of California, San Diego · R01 · FY2024 · DA

Maintaining opioid analgesia and preventing addiction with hypocretin antagonism

$561,974
Jerome M Siegel · University Of California Los Angeles · R01 · FY2025 · DA

Maintaining opioid analgesia and preventing addiction with hypocretin antagonism

$561,974
Jerome M Siegel · University Of California Los Angeles · R01 · FY2024 · DA

Maintaining opioid analgesia and preventing addiction with hypocretin antagonism

$561,974
Jerome M Siegel · University Of California Los Angeles · R01 · FY2023 · DA

A randomized trial of urban vacant lot stabilization and substance abuse outcomes

$561,941
Charles C. Branas · University Of Pennsylvania · R01 · FY2012 · AA

Interaction of Emotional Perception and Visual Attention

$561,912
Luiz Pessoa · Univ Of Maryland, College Park · R01 · FY2015 · MH

Smoking Cessation for Head and Neck Cancer Patients

$561,908
Fox Chase Cancer Center · R01 · FY2004 · CA

Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Markets and Drug Tourism

$561,819
Steffanie A Strathdee · University Of California, San Diego · R01 · FY2021 · DA

Identification of small molecules that regulate endogenous opioid signaling by inhibiting angiotensin converting enzyme

$561,759
Swati S More · University Of Minnesota · R01 · FY2025 · DA

Mechanisms of Sleep Disruption Hyperalgesia

$561,723
Michael T Smith · Johns Hopkins University · R01 · FY2016 · DA

Localized and distributed real-time fMRI approaches to facilitate self control in

$561,721
Pearl H Chiu · Virginia Polytechnic Inst And St Univ · R33 · FY2012 · DA

CT Climical Justice-DATS Research Initiative

$561,686
Connecticut St Dept Of Mh/Addiction Srvs · U01 · FY2005 · DA